Cardiac Imaging: Page 22

Associations recommend CCTA as front-line test

By AuntMinnie.com staff writers

The American Heart Association, the American College of Cardiology, and other groups have jointly given coronary computed tomographic angiography (CCTA) a class I recommendation as a front-line testing strategy.

October 28, 2021

Cardiac MRI assesses myocarditis after COVID-19 vaccination

By Kate Madden Yee

Myocarditis after COVID-19 mRNA vaccination is rare, but it does occur, and cardiac MRI helps clinicians identify it, according to a study published October 27 in the American Journal of Roentgenology.

October 28, 2021

Coreline Soft highlights CAC research

By AuntMinnie.com staff writers

Advanced visualization and artificial intelligence software developer Coreline Soft is directing attention to recent research involving its coronary artery calcium (CAC) image analysis software.

October 25, 2021

Body composition on CT lung screening can spot at-risk patients

By Erik L. Ridley

Body composition analysis on CT lung cancer screening exams can identify patients at risk of death or hospitalization in the coming years, according to a presentation at the virtual Chest 2021 meeting.

October 17, 2021

OneProjects raises $17M to launch imaging platform

By AuntMinnie.com staff writers

OneProjects has raised a total of $17 million in a new financing round to fund the launch of its proprietary 4D cardiac imaging platform, Verafeye.

October 13, 2021

Cardiac MRI is 'technique of choice' for imaging suspected heart tumors

By Kate Madden Yee

Cardiac MRI is the "technique of choice" for imaging suspected cardiac tumors, with a high accuracy rate and prognostic value, according to a study published September 21 in the European Heart Journal.

October 7, 2021

FDA signs off on change to contraindications for GE's Optison agent

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved the removal of hypersensitivity to blood and blood products from the listed contraindications for GE Healthcare's Optison echocardiography contrast agent.

October 4, 2021

Are radiologists regaining control of cardiac imaging?

By Kate Madden Yee

The rate of coronary CT angiography exams performed by radiologists in U.S. hospitals increased by more than 300% between 2010 and 2019, indicating that radiologists could be regaining control of cardiac imaging, according to a September 30 paper in Radiology: Cardiothoracic Imaging.

September 30, 2021

GE rolls out MyoSPECT cardiac nuclear medicine scanner

By AuntMinnie.com staff writers

GE Healthcare is rolling out a new dedicated nuclear medicine scanner called MyoSPECT. The system sports an extended field of view and automated workflow, as well as detectors based on digital cadmium zinc telluride technology.

September 29, 2021

PET links heart disease risk and PTSD

By Will Morton

PET imaging has found a link between heart disease risk and post-traumatic stress disorder (PTSD) in Vietnam War veterans, according to a study published September 27 in Biological Psychiatry.

September 28, 2021

Zebra Medical wins FDA nod for CAC analysis software

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthCCSng, an AI-based software application for analysis of coronary artery calcium (CAC) on nongated CT studies.

September 26, 2021

PET detects activity in early atherosclerosis

By Will Morton

PET imaging has shown that an experimental radiotracer can detect cellular activity in the artery walls of patients with atherosclerosis, according to a study published September 18 in the Journal of Nuclear Medicine.

September 20, 2021

Previous Page

Page 22 of 325

Next Page